Birmingham, West Midlands -- (SBWIRE) -- 12/17/2013 -- Value Penny Stocks issues special report on YRC Worldwide, Inc. (NASDAQ:YRCW), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Dynavax Technologies Corporation (NASDAQ:DVAX).
YRC Worldwide, Inc. (NASDAQ:YRCW) opened its last trade at the price of $13.16. Its closing price was $13.05. The company traded with the total volume of 3,842,019 shares, while its average trading volume remained 1.454 million shares. The beta of this stock stands at 3.21. YRC Worldwide Inc., through its subsidiaries, provides various transportation services primarily in North America. Its YRC Freight segment offers various services for the transportation of industrial, commercial, and retail goods, such as apparel, appliances, automotive parts, chemicals, food, furniture, glass, machinery, metal, metal products, non-bulk petroleum products, rubber, textiles, wood, and other manufactured products or components.
Can Investors Bet on YRCW after this News update? Find out in this Research Report
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) closed at $2.82 with the total traded volume of 3,831,842 shares, along with average volume of 2.46 million shares. The 52 week range of the stock remained $2.49 - $6.00, while its day lowest price was $2.81. The share price hit the day highest price of $3.00. Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States.
Is AVNR a Solid Investment at These Levels? Read This Report For Details
Dynavax Technologies Corporation (NASDAQ:DVAX) traded on volume of 3,655,861 shares in the last session against average volume of 5.08 million shares. The company started its trading session with the price of $1.67 and closed at $1.79. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences.
How Should Investors Trade DVAX Now? Don’t Miss out a Special Trend Analysis
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)